ACET Q3 2019 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$7M

Gross Profit

-$7M100.0% margin

Operating Income

-$15M216.0% margin

Net Income

-$15M209.7% margin

EPS (Diluted)

$-12.80

QoQ Revenue Growth

-313.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$391,000

Balance Sheet

Total Assets

$122M

Total Liabilities

$12M

Stockholders' Equity

$110M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$7M	$0	—
Gross Profit	-$7M	$0	—
Operating Income	-$15M	-$9M	-68.6%
Net Income	-$15M	-$8M	-75.8%